467 related articles for article (PubMed ID: 17322170)
1. Fetal-derived trophoblast use the apoptotic cytokine tumor necrosis factor-alpha-related apoptosis-inducing ligand to induce smooth muscle cell death.
Keogh RJ; Harris LK; Freeman A; Baker PN; Aplin JD; Whitley GS; Cartwright JE
Circ Res; 2007 Mar; 100(6):834-41. PubMed ID: 17322170
[TBL] [Abstract][Full Text] [Related]
2. BeWo cells stimulate smooth muscle cell apoptosis and elastin breakdown in a model of spiral artery transformation.
Harris LK; Keogh RJ; Wareing M; Baker PN; Cartwright JE; Whitley GS; Aplin JD
Hum Reprod; 2007 Nov; 22(11):2834-41. PubMed ID: 17905750
[TBL] [Abstract][Full Text] [Related]
3. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response.
Jiang CC; Chen LH; Gillespie S; Kiejda KA; Mhaidat N; Wang YF; Thorne R; Zhang XD; Hersey P
Cancer Res; 2007 Jun; 67(12):5880-8. PubMed ID: 17575157
[TBL] [Abstract][Full Text] [Related]
4. T cells and eosinophils in bronchial smooth muscle cell death in asthma.
Solarewicz-Madejek K; Basinski TM; Crameri R; Akdis M; Akkaya A; Blaser K; Rabe KF; Akdis CA; Jutel M
Clin Exp Allergy; 2009 Jun; 39(6):845-55. PubMed ID: 19400895
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha-induced apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-dependent and -independent manner.
Yanase N; Kanetaka Y; Mizuguchi J
Oncol Rep; 2007 Oct; 18(4):1031-8. PubMed ID: 17786370
[TBL] [Abstract][Full Text] [Related]
6. Physiological smooth muscle cell apoptosis contributes to the uterine vascular remodeling in human early pregnancy.
Helwig JJ; Le Bouteiller P
Circ Res; 2007 Mar; 100(6):754-6. PubMed ID: 17395879
[No Abstract] [Full Text] [Related]
7. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
Saitou Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Hum Pathol; 2005 Oct; 36(10):1066-73. PubMed ID: 16226105
[TBL] [Abstract][Full Text] [Related]
8. Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function.
Li Y; Wang H; Wang Z; Makhija S; Buchsbaum D; LoBuglio A; Kimberly R; Zhou T
Cancer Res; 2006 Sep; 66(17):8520-8. PubMed ID: 16951164
[TBL] [Abstract][Full Text] [Related]
9. TRAIL pathway components and their putative role in granulosa cell apoptosis in the human ovary.
Jääskeläinen M; Kyrönlahti A; Anttonen M; Nishi Y; Yanase T; Secchiero P; Zauli G; Tapanainen JS; Heikinheimo M; Vaskivuo TE
Differentiation; 2009 Apr; 77(4):369-76. PubMed ID: 19281785
[TBL] [Abstract][Full Text] [Related]
10. Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis.
Secchiero P; Zauli G
Curr Opin Hematol; 2008 Jan; 15(1):42-8. PubMed ID: 18043245
[TBL] [Abstract][Full Text] [Related]
11. Human agonistic antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 induces cytotoxicity and apoptosis in prostate cancer and bladder cancer cells.
Shimada O; Wu X; Jin X; Nouh MA; Fiscella M; Albert V; Matsuda T; Kakehi Y
Urology; 2007 Feb; 69(2):395-401. PubMed ID: 17320696
[TBL] [Abstract][Full Text] [Related]
12. High levels of endogenous tumor necrosis factor-related apoptosis-inducing ligand expression correlate with increased cell death in human pancreas.
Sanlioglu AD; Dirice E; Elpek O; Korcum AF; Balci MK; Omer A; Griffith TS; Sanlioglu S
Pancreas; 2008 May; 36(4):385-93. PubMed ID: 18437085
[TBL] [Abstract][Full Text] [Related]
13. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma.
Shiraki K; Yamanaka T; Inoue H; Kawakita T; Enokimura N; Okano H; Sugimoto K; Murata K; Nakano T
Int J Oncol; 2005 May; 26(5):1273-81. PubMed ID: 15809718
[TBL] [Abstract][Full Text] [Related]
14. TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege.
Phillips TA; Ni J; Pan G; Ruben SM; Wei YF; Pace JL; Hunt JS
J Immunol; 1999 May; 162(10):6053-9. PubMed ID: 10229846
[TBL] [Abstract][Full Text] [Related]
15. TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate.
Vindrieux D; Réveiller M; Florin A; Blanchard C; Ruffion A; Devonec M; Benahmed M; Grataroli R
J Cell Physiol; 2006 Mar; 206(3):709-17. PubMed ID: 16245307
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells.
Secchiero P; Melloni E; Corallini F; Beltrami AP; Alviano F; Milani D; D'Aurizio F; di Iasio MG; Cesselli D; Bagnara GP; Zauli G
Stem Cells; 2008 Nov; 26(11):2955-63. PubMed ID: 18772312
[TBL] [Abstract][Full Text] [Related]
17. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis.
Geserick P; Drewniok C; Hupe M; Haas TL; Diessenbacher P; Sprick MR; Schön MP; Henkler F; Gollnick H; Walczak H; Leverkus M
Oncogene; 2008 May; 27(22):3211-20. PubMed ID: 18084329
[TBL] [Abstract][Full Text] [Related]
18. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.
Zhang Y; Zhang B
Mol Cancer Res; 2008 Dec; 6(12):1861-71. PubMed ID: 19074831
[TBL] [Abstract][Full Text] [Related]
19. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice.
Secchiero P; Candido R; Corallini F; Zacchigna S; Toffoli B; Rimondi E; Fabris B; Giacca M; Zauli G
Circulation; 2006 Oct; 114(14):1522-30. PubMed ID: 17000905
[TBL] [Abstract][Full Text] [Related]
20. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
Maduro JH; de Vries EG; Meersma GJ; Hougardy BM; van der Zee AG; de Jong S
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):543-52. PubMed ID: 18793956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
